Entity usage

Jump to navigation Jump to search

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

List of pages that use a given entity

Showing below up to 25 results in range #1 to #25.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Section 1: Introduction (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  2. Disclosure statement (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  3. Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  4. Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  5. Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  6. Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  7. Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  8. Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  9. Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  10. Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  11. Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  12. Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  13. Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  14. Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  15. Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  16. Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  17. Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  18. Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  19. Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  20. Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  21. Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  22. Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  23. Section 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  24. Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en
  25. Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265): Title, Label: en

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:EntityUsage/Q8414"